Previously, the identified D486Y variant THBD protein was shown to exhibit defects in suppressing activation of the alternative complement pathway through factor I-mediated C3b inactivation in vitro, suggesting its role in the pathogenesis of aHUS [14]. The gene discussed is C3; the disease is atypical hemolytic-uremic syndrome.